WEDNESDAY, June 2 (HealthDay News) -- A new study may reassure parents about what they believe -- or hope -- is true: Teenagers tend to mature as they get older.

WEDNESDAY, June 2 (HealthDay News) -- Drinking and driving among college students is still a major public health problem, new research reveals, with one in five admitting to driving while drunk and 40 percent acknowledging they have ridden with a drunk driver.

WEDNESDAY, June 2 (HealthDay News) -- Black men are already known to be at higher risk of developing prostate cancer than white men, but now a new study reports that they also appear to be more likely to develop aggressive forms of the disease.

(HealthDay News) -- If your doctor has recommended surgery as a solution to chronic back pain, the American Academy of Orthopaedic Surgeons offers these suggestions to aid in your recovery:

(HealthDay News) -- While today's pacemakers are built to withstand the daily grind of modern life, they still require care.

WEDNESDAY, June 2 (HealthDay News) -- Patients suffering from the eating disorder anorexia nervosa can actually lose brain volume, but new research suggests that, with special treatment, adult patients can regain the gray matter that they lost from relentless dieting.

WEDNESDAY, June 2 (HealthDay News) -- A review of three common surgical techniques used in tonsillectomies and related procedures has pinpointed which method has the lowest level of complications.

WEDNESDAY, June 2 (HealthDay News) -- The painkiller a woman takes after a mastectomy may influence the odds of breast cancer recurrence, a new study suggests.

WEDNESDAY, June 2 (HealthDay News) -- A modified form of the measles virus could become a treatment for a kind of brain tumor in children, researchers report.

TUESDAY, June 1 (HealthDay News) -- Despite prior research identifying both genetic risks for breast cancer as well as risks associated with lifestyle and environmental factors, a new British study reveals that the two types of risk pools appear to operate independently of one another.

WEDNESDAY, June 2 (HealthDay News) -- Tumor size among prostate cancer patients appears to be linked to patient weight, with heavier men having larger tumors, a new study reveals.

WEDNESDAY, June 2 (HealthDay News) -- Two new tests promise to cut down on the number of biopsies now taken from men suspected of having prostate cancer, researchers report.

WEDNESDAY, June 2 (HealthDay News) -- People suffering from Parkinson's disease can benefit from deep brain stimulation in either one of two sites in the brain, a new study finds.

WEDNESDAY, June 2 (HealthDay News) -- More than 40 percent of unmarried U.S. teenagers -- or 4.3 million teen males and females -- have had sex at least once, a new U.S. government report shows.

WEDNESDAY, June 2 (HealthDay News) -- If you shudder at the thought of having to start the day without a cup of coffee, new research hints at why you may feel this way.

WEDNESDAY, June 2 (HealthDay News) -- Conventional wisdom says older people make less risky -- and less sound -- decisions, but now a new study suggests otherwise.

WEDNESDAY, June 2 (HealthDay News) -- People with tidy homes are more likely to be physically active than those with messy dwellings, new findings suggest.

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

WEDNESDAY, June 2 (HealthDay News) -- The injected drug Prolia (denosumab) has been approved by the U.S. Food and Drug Administration to treat post-menopausal women at high risk of bone fracture due to osteoporosis.

WEDNESDAY, June 2 (HealthDay News) -- For patients with early stage breast cancer, taking chemotherapy drugs sequentially over six months helps improve their survival compared to taking them at the same time over a shorter three-month span, a new study found.

WEDNESDAY, June 2 (HealthDay News) -- In people with pre-diabetes, a low-dose combination of two diabetes drugs -- metformin and Avandia (rosiglitazone) -- appeared to reduce the progression to type 2 diabetes, new research shows.